Moleculin Biotech, Inc. Other Noncash Income (Expense)
Moleculin Biotech, Inc. (MBRX) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2019-02-21
- Moleculin Biotech, Inc. other noncash income (expense) for the quarter ending 2018-12-31 was $0.00.
- Moleculin Biotech, Inc. other noncash income (expense) for the quarter ending 2017-12-31 was $0.00.
- Moleculin Biotech, Inc. other noncash income (expense) for the quarter ending 2016-12-31 was $0.00.
- Moleculin Biotech, Inc. other noncash income (expense) for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- Moleculin Biotech, Inc. other noncash income (expense) for fiscal 2017 was $9.00K.
- Moleculin Biotech, Inc. other noncash income (expense) for fiscal 2016 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $9.00K 10-K · filed 2019-02-21 | |
| 2017-09-30 | $9.00K 10-Q · filed 2018-11-13 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $0.00 10-K · filed 2018-03-28 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |